FDA panel mixed on approving Cymbalta for pain (AP)
AP – A group of federal health experts narrowly voted to expand approval of a best-selling antidepressant on Thursday, though panelists disagreed over which types of pain the pill effectively treats.
Read More: FDA panel mixed on approving Cymbalta for pain
(AP)